INVITATION
F. Hoffmann-La Roche Ltd - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC
INVITATION
Sanofi - ER+ / HER2- Breast Cancer: What’s next for patients & providers?
F. Hoffmann-La Roche Ltd - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC
Sanofi - ER+ / HER2- Breast Cancer: What’s next for patients & providers?